Journal Mobile Options

Vol. 82, No. 2, 2005

Issue release date: February 2006

Select / Unselect all
Original Paper

Absence of a Difference in the Neurosecretory Activity of Supraoptic Nucleus Vasopressin Neurons of Neuroleptic-Treated Schizophrenic Patients

Malidelis Y.I. · Panayotacopoulou M.T. · van Heerikhuize J.J. · Unmehopa U.A. · Kontostavlaki D.P. · Swaab D.F.
Neuroendocrinology 2005;82:63–69 (DOI:10.1159/000090981)

Histaminergic Neurons Are Involved in the Orexigenic Effect of Orexin-A

Jørgensen E.A. · Knigge U. · Watanabe T. · Warberg J. · Kjaer A.
Neuroendocrinology 2005;82:70–77 (DOI:10.1159/000090982)

Sex Differences in Methamphetamine-Evoked Striatal Dopamine Output Are Abolished following Gonadectomy: Comparisons with Potassium-Evoked Output and Responses in Prepubertal Mice

Dluzen D.E. · Salvaterra T.J.
Neuroendocrinology 2005;82:78–86 (DOI:10.1159/000090983)

Insulin-Like Growth Factor-1 Increases Intracellular Calcium Concentration in Human Primary Neuroendocrine Pancreatic Tumor Cells and a Pancreatic Neuroendocrine Tumor Cell Line (BON-1) via R-Type Ca2+ Channels and Regulates Chromogranin A Secretion in BON-1 Cells

Mergler S. · Strauss O. · Strowski M. · Prada J. · Drost A. · Langrehr J. · Neuhaus P. · Wiedenmann B. · Ploeckinger U.
Neuroendocrinology 2005;82:87–102 (DOI:10.1159/000091008)

Trade-Off between L-Thyroxin and Melatonin in Immune Regulation of the Indian Palm Squirrel, Funambulus pennanti during the Reproductively Inactive Phase

Rai S. · Haldar C. · Singh S.S.
Neuroendocrinology 2005;82:103–110 (DOI:10.1159/000091034)

Differential Protective Properties of Estradiol and Tamoxifen against Methamphetamine-Induced Nigrostriatal Dopaminergic Toxicity in Mice

D’Astous M. · Mickley K.R. · Dluzen D.E. · Di Paolo T.
Neuroendocrinology 2005;82:111–120 (DOI:10.1159/000091206)

Secretagogin Is a Novel Marker for Neuroendocrine Differentiation

Birkenkamp-Demtröder K. · Wagner L. · Brandt Sørensen F. · Bording Astrup L. · Gartner W. · Scherübl H. · Heine B. · Christiansen P. · Ørntoft T.F.
Neuroendocrinology 2005;82:121–138 (DOI:10.1159/000091207)